fda warning letter glp-1 solution september 9 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Issues Warning Letters Against

We are a community of thousands of tinnitus patients and providers who work together to find a range of solutions, even in the most complex cases

Driscoll, M

The AMG 133 murine surrogate stimulates cAMP production in CHO-K1 cells expressing mouse GLP-1R with EC 50 values of 90.6 pM (Extended Data Fig

Pioneering research in Microdosing GLP-1 The AgelessRx Applied Science Team is leading the first clinical trial focused on the healthspan-enhancing potential of Microdosing GLP-1 Ongoing observational study including long-term tracking of diverse health outcomes in over 1,000 patients using a growing real-world database of patient-reported data Clinical collaborations are currently in development to expand the scope and impact of this research How it works GLP-1s bind to GLP-1 receptors beyond the brain and gut, reaching the heart, kidneys, blood vessels, and immune cells Shown to support signaling to longevity-related pathways like AMPK and mTOR, affecting key Hallmarks of Aging like oxidative stress, inflammation, DNA repair, mitochondrial function, and autophagy At low doses, may subtly restore balance to hormone signaling, reduce inflammation (immune cells), improve cognitive function, and cardiometabolic health Effects may vary based on individual biology and with factors including inflammation, weight, lifestyle, metabolic health, and health history